1.
Charcot J-M, Joffroy A. Deux cas d’atrophie musculaire progressive: avec lésions de la
substance grise et des faisceaux antérolatéraux de la moelle épinière. Masson; 1869.
2.
Michael A van Es, Orla Hardiman, Adriano Chio, et al. Amyotrophic lateral sclerosis. Lancet.
2017; 390:2084-98.
3.
N. Shahrizalia, G. Sobue, S. Kuwabara, et al. Amyotrophic Lateral Screlosis and motor
neuron syndrome in Asia. J Neurol Neurosurg Psychiatry. 2016; 87:821-830.
4.
Marc Christopher Emos, Sanjeev Agarwal. Neuroanatomy, Upper Motor Neuron Lesion.
StatPearls. 2020.
5.
Kinaan Javed, Daniel T. Daly. Neuroanatomy, Upper Motor Neuron Lesion. StatPearls. 2020.
6.
Sara Zarei, Karen Carr, Luz Reiley, et al. A comprehensive review of amyotrophic lateral
sclerosis. Surgical Neurology International. 2015; 6:171.
7.
Manoj Kumar Jaiswal. Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis
drugs. Med Res Rev. 2019; 39:733-748.
8.
Mitsumoto H, Brooks BR, Silani V, et al. Clinical trials in amyotrophic lateral sclerosis: why
so many negative trials and how can trials be improved? Lancet Neurol. 2014; 13:1127–38.
9.
Nimeshan Geevasinga, Clement T. Loy, Parvathi Menon, et al. Awaji criteria improves the
diagnostic sensitivity in amyotrophic lateral sclerosis: A systematic review using individual
patient data. Clinical Neurophysiology. 2016; 127:2684-2691.
10. Benjamin Rix Brooks, Robert G Miller, Michael Swash, et al. El Escorial: Reviser criteria for
the diagnosis of amyotrophic lateral sclerosis. ALS and other motor neuron disorders 2000;
1:293-299.
11. Mamede de Carvallo, Reinhard Dengler, Andrew Eisen, et al. Electrodiagnostic criteria for
diagnosis of ALS. Clinical Neurophysiology 119(2008)497-503
12. Michael A vans Es, Orla Hardiman, Adriano Chio, et al. Amyotrophic lateral sclerosis. Lancet.
2017; 39:2084-98.
13. Mana Higashihara, Masahiro Sonoo, Ichiro Imafuku, et al. Fasciculation potentials in
amyotrophic lateral sclerosis and the diagnostic yield of the Awaji algorithm. Muscle & Nerve.
2012; 45:175-182.
14. Leslie I. Grad, Guy A. Rouleau, John Ravits, et al. Clinical Spectrum of Amyotrophic Lateral
Sclerosis (ALS). Cold Spring Harb Perspect Med. 207; 7: a024117.
15. Mamede de Carvalho, Michael Swash, et al. Lower motor neuron dysfunction in ALS.
Clinical Neurophysiology. 2016; 127:2670-2681.
145
16. Yu-ichi Noto, Sonoko Misawa, Kazuaki Kanai, et al. Awaji ALS criteria increase the
diagnostic sensitivity in patients with bulbar onset. Clinical Neurophysiology. 2012; 123:382385.
17. Barker AT, Jalinous R, Freeston IL, et al. Non-invasive magnetic stimulation of human motor
cortex. Lancet 1985; 1:1106-1107.
18. N. Alvarez, L. Diez, C. Avellaneda, et al. Relevance of the pyramidal syndrome in
amyotrophic lateral sclerosis. Neurologia. 2018; 33(1):8-12.
19. Amassian VE, Stewart M, Quirk GJ, et al. Physiological basis of motor effects of a transient
stimulus to cerebral cortex. Neurosurgery 1987; 20:74-93.
20. P.M. Rossini, D. Burke, R. Chen, et al. Non-invasive electrical and magnetic stimulation of
the brain, spinal cord, roots and peripheral nerves: Basic principles and procedures for
routine clinical and research application. An updated report from an I.F.C.N Committee.
Clinical Neurophysiology 126 (2015) 1071-1107.
21. T. Kujirai, J.C. Rothwell, B.L. Day, et al. Corticocortical inhinition in human motor cortex.
Journal of Physiology. 1993; 471:501-519.
22. A.G. Floyd, Q.P. Yu, P. Piboolnurak, et al. Transcranial magnetic stimulation in ALS.
Neurology 2009; 72:498-504.
23. Jean Pouget, Sylvie Trefouret, Shaharam Attarian, et al. Transcranial magnetic stimulation
(TMS): compared sensitivity of different motor response parameters in ALS. ALS and other
motor neuron disorders 2000 (suppl2), S45-S49.
24. Steve Vucic, Ulf Ziemann, Andrew Eisen, et al. Transcranial magnetic stimulation and
amyotrophic lateral sclerosis: pathophysiological insights. J Neurol Neurosurg Psychiatry
2013; 84:1161-1170.
25. Xiang Yi, Karen M, Fisher, et al. Differences between Han Chinese and Caucasians in
transcranial magnetic stimulation parameters. Exp Brain Res 2014; 232:545-553.
26. Parvathi Menon, Nimeshan Geevasinga, Con Yiannikas, et al. Sensitivity and specificity of
threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral
sclerosis: a prospective study. Lancet Neurol. 2015; 14:478-84.
27. F. Awiszus. TMS and threshold hunting. Transcranial Magnetic Stimulation and
Transcranial Direct Current Stimulation (Supplements to Clinical Neurophysiology, vol. 56)
2003.
28. V. Di Lazzaro, A. Oliviero, P. Profice, et al. The diagnostic value of motor evoked potentials.
Clinical Neurophysiology 110 (1999) 1297-1307.
29. S. Gilman, G.K. Wenning, P.A. Low, et al. Second consensus statement on the diagnosis of
multiple system atrophy. Neurology 2008; 71:670-677.
30. Colin Quinn, Christyn Edmundson, Nablia Dahodwala, et al. Reliable and efficient scale to
146
assess upper motor neuron disease burden in amyotrophic lateral sclerosis. Muscle & Nerve
2020; 61:508-534
31. K.E. Brown, K.R. Lohse, I.M.S. Mayer, et al. The reliability of commonly used
electrophysiology measures. Brain Stimulation. 2017; 10:1102-1111.
32. D Claus. Central motor conduction: method and normal results. Muscle & Nerve. 1990(13);
1125-1132.
33. Matsumoto H, Hanajima R, Shirota Y, et al. Cortico-conus motor conduction time (CCCT)
for legs. Clinical Neurophysiology 2010; 121:1930-1933.
34. Sobue G, Hashizume Y, Mitsuma T, et al. Size-dependent myelinated fibers loss in the
corticospinal tract in Shy-Drager syndrome and amyotrophic lateral sclerosis. Neurology.
1987; 37:529-532.
35. Parvathi Menon, Con Yiannikas, Matthew C. Kiernan, et al. Regional motor cortex
dysfunction in amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology.
2019; 6:1373-1382.
36. 浜野健三：Babinski 反射．脳と発達．1988; 20:343-345.
37. Gubbay SS, Kahana E, Zilber N, et al. Amyotrophic lateral sclerosis. A study of its
presentation and prognosis. J Neurol. 1985; 232:285-300.
38. Caroscio JT, Mulvihill MN, Sterling R, et al. Amyotrophic lateral sclerosis: its natural history.
Neurol Clin. 1987; 5:1-8.
39. Matthew B. Harms, Robert H. Baloh, et al. Clinical Neurogenetice : Amyotrophic Lateral
Sclerosis. Neurol Clin. 2013; 31(4)
40. Atsuhiko Sugiyama, Noriko Sato, Yukio Kimura, et al. Exploring the frequency and clinical
background of the “zebra sign” in amyotrophic lateral sclerosis and multiple system atrophy.
Journal of the Neurological Sciences 401 (2019) 90-94.
41. N.P. Quinn, C.D. Marsden. The motor disorder of multiple system atrophy. J Neurol
Neurosurg Psyciatry. 56 (1993) 1239-1242.
42. Köllensperger M, Geser F, Ndayisaba JP, et al. Presentation, diagnosis, and management of
multiple system atrophy in Europe: final analysis of the European multiple system atrophy
registry. Mov Disord 2010; 25:2604-12.
43. Dan L. Longo, Alessandra Franciulli, Gregor K. Wenning, et al. Multiple-System Atrophy. N
Engl J Med 2015; 372:249-63.
44. A. Eusebio, J.P. Azulay, T. Witjas, et al. Assessment of cortico-spinal tract impairment in
multiple system atrophy using transcranial magnetic stimulation. Clinical Neurophysiology
118 (2007) 815-823.
45. G. Abbruzzese, R. Marchese, C. Trompetto, et al. Sensory and motor evoked potentials in
multiple system atrophy: a comparative study with parkinson’s disease. Mov Disord. 12
147
(1997) 315-321.
46. A. Cruz Martinez, J. Arpa, M. Alonso, et al. Transcranial magnetic stimulation in multiple
system and late onset cerebellar atrophies. Acta neurol Scand. 92 (1995) 218-224.
47. T.N. Schriefer, C.W. Hess, K.R. Mills, et al. Central motor conduction studies in motor
neuron disease using magnetic brain stimulation. Electroencephalography and clinical
Neurophysiology 1989; 74:431-437.
48. Kerry R. Mills, Kannan A. Nithi. Peripheral and central motor conduction in amyotrophic
lateral sclerosis. Journal of the Neurological Sciences. 159 (1998) 82-87.
49. Y. Ugawa, T. Shimpo, T. Mannen, et al. Central motor conduction in cerebrovascular disease
and motor neuron disease. Acta Neurol Scand. 1998: 78;297-306.
50. Abele M, Schulz JB, Bruk K, et al. Evoked potentials in multiple system atrophy (MSA). Acta
Neurol Scand. 101 (2000) 111-115.
51. Alessandra Fanciulli, Iva Stankovic, Florian Krismer, et al. Multiple system atrophy.
International Review of Neurobiology. 2019; 149:137-192.
52. Robert Chen, Didier Cros, Antonio Curra, et al. The clinical diagnostic utility of transcranial
magnetic stimulation: Report of an IFCN committee. Clinical Neurophysiology 2008;
119:504-532.
53. Carlo Civardi, Alessandra Collini, Letizia Mazzini, et al. single-pulse transcranial magnetic
stimulation in amyotrophic lateral sclerosis. Muscle and Nerve. 2020; 61:330-337
54. De Carvalho M. Testing upper motor neuron function in amyotrophic lateral sclerosis: the
most difficult task of neurophysiology. Brain (2012) 135:2581–2.
55. A. Heald, D. Bates, N.E.F. Cartlidge, et al. Longitudinal study of central motor conduction
time following stroke. Brain. 1993: 116:1355-1370.
56. Jokelainen M. Amyotrophic lateral sclerosis in Finland Ⅱ. Clinical characteristics. Acta
Neurol Scand. 1977; 56:194-204.
57. Yu Wang, Na Liu, Zhecheng Zhang, et al. Respiratory electrophysiologic in chronic
obstructive pulmonary disease. Medicine. 2019: 98:1 (e13993)
58. N. Geevasinga, P. Menon, C. Yiannikas, et al. Diagnostic utility of cortical excitability studies
in amyotrophic lateral sclerosis. European Journal of Neurology. 2014: 21;1451-1457.
59. G.K. Wenning, F. Tison, Y. Ben Shlomo, et al. Multiple system atrophy: A review of 203
pathologically proven cases. Movement Disorder. 1997; 12:133-147.
60. Tsuchiya K, Ozawa E, Haga C, et al. Constant involvement of the Betz cells and pyramidal
tract in multiple system atrophy: a clinicopathological study of seven autopsy cases. Acta
Neuropathol. 2000; 99:628-636.
61. Andrew Eisen, Bhanu Pant, Heather Stewart, et al. Cortical Excitability in Amyotrophic
Lateral Sclerosis: A Clue to Pathogenesis. Can. J. Neurol. Sci. 1993: 20;11-16.
148
62. Y. Osaki, Y.B. Shlomo, A.J. Lees, et al. A Validation Exercise on the New Consensus Criteria
for Multiple System Atrophy. Movement Disorders. 2009; 24:2272-2276.
63. N. Geevasinga, P. Menon, D.B. Scherman, et al. Diagnostic criteria in amyotrophic lateral
sclerosis. A multicenter prospective study. Neurology. 2016; 87:684-690.
64. Vucic S, Howells J, Trevillion L, Kiernan MC, et al. Assessment of cortical excitability using
threshold tracking techniques. Muscle & Nerve. 2006; 33:477-86.
65. Adrian ED, Moruzzi G. Impulses in the pyramidal tract. J Physiol 1993; 97:153-99.
66. S. Groppa, A. Oliviero, A. Eisen, et al. A practical guide to diagnostic transcranial magnetic
stimulation: Report of an IFCN committee. Clinical Neurophysiology 123 (2012) 858-882.
67. Carlo Miniussi, Justin A Harris, Manuela Ruzzoli, et al. Modelling non-invasive brain
stimulation in cognitive neuroscience. Neuroscience and Biobehavioral Reviews. 2013;
35:1702-1712.
68. Eric M. Wassermann. Variation in the response to transcranial magnetic brain stimulation in
the general population. Clinical Neurophysiology. 2002; 113:1165-1171.
69. Carlo Miniussi, Justin A Harris, Manuela Ruzzoli, et al. Modelling non-invasive brain
stimulation in cognitive neuroscience. Neuroscience and Biobehavioral Reviews. 2013;
35:1702-1712.
70. A.M. Hermsen, A. Haag, C. Duddek, et al. Test-retest reliability of single and paired pulse
transcranial magnetic stimulation parameters in healthy subjects. Journal of the Neurological
Sciences. 2016; 362:209-216.
71. Rossini PM, Barker AT, Berardelli A, et al. Non-invasive electrical and magnetic stimulation
of the brain, spinal cord, and roots: basic principles and procedures for routine clinical
application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol. 1994;
91:79-92.
72. C. Tranulis, B. Gueguen, A. Pham-Scottez, et al. Motor threshold in transcranial magnetic
stimulation: comparison of three estimation methods. Clinical Neurophysiology. 2006; 36:17.
73. Mana Higashihara, Mehdi A.J. Van den Bos, Parvathi Menon, et al. Interneuronal networks
mediate cortical inhibition and facilitation. Clinical Neurophysiology. 2020; 131:1000-1010.
74. Friedemann Awiszus. Fast estimation of transcranial magnetic stimulation motor threshold:
is it safe? Brain Stimulation. 2011; 4:58-59.
75. Nicola Modugno, Antonio Curra, Francesca Gilio, et al. Transcranial Magnetic Stimulation
in Movement Disorders.
76. 藤本健一,佐山節子,静間奈美ら．経頭蓋磁気刺激検査にて皮質内抑制機構を経時的に観察し
た臨床診断 corticobasal degeneration の 1 例．臨床神経．2000; 40:701-706.
77. Julia C. Nantes, Jidan Zhong, Scott A, et al. Holmes. Cortical Damage and Disability in
149
Multiple Sclerosis: Relation to Intracortical Inhibition and Facilitation. Brain Stimulation.
2016; 9: 566-573.
78. Thusharika Dissanayaka, Maryam Zoghi, Michael Farrell, et al. Comparison of RossiniRothwell and adaptive threshold-hunting methods on the stability of TMS induced motor
evoked potentials amplitudes. J. Neuro. Res. 2018; 96:1758-1765.
79. A.M. Hermsen, A. Haag, C. Duddek, et al. Test-retest reliability of single and paired pulse
transcranial magnetic stimulation parameters in healthy subjects. Journal of the Neurological
Sciences. 2016; 362:209-216.
80. B.I. Silbert, H.I. Patterson, D.D. Pevcic, et al. A comparison of relative-frequency and
threshold-hunting methods to determine stimulus intensity in transcranial magnetic
stimulation. Clinical Neurophysiology. 2013; 124:708-712.
81. Gintaute Samusyte, Hugh Bostock, John Rothwell, et al. Short-interval itracortical inhibition:
Comparison between conventional and threshold-tracking techniques. Brain Stimulation.
2018; 11:806-817.
82. Steve Vucic, Matthew C. Kiernan. Transcranial Magnetic Stimulation for the Assessment of
Neurodegenerative Disease. Neurotherapeutics. 2017; 14:91-106.
83. C.M. Lloyd, M.P. Richardson, D.J. Brooks, et al. Extramotor involvement in ALS: PET
studies with the GABAA ligand [11C] flumazenil. Brain. 2000; 123:2289-2296.
84. Tokimura H, Ridding MC, Tokimura Y, et al. Short latency facilitation between pairs of
threshold magnetic stimuli applied to human motor cortex. Electroencephalogr Clin
Neurophysiol 1996; 103:263-72.
85. Nagako Murase, Bulent Cengiz, John C, et al. Rothwell. Inter-individual Variation in the
After-effect of Paired Associative Stimulation can be Predicted from Short-interval
Intracortical Inhibition with the Threshold Tracking Method. Brain Stimulation. 2015;
9:105-113.
86. Steve Vucic, Matthew C. Kiernan. Novel threshold tracking techniques suggest that cortical
hyperexcitability is an early feature of motor neuron disease. Brain. 2006; 129:2436-2446.
87. William J. Triggs, Ron Calvanio, Minna Levine, et al. Transcranial magnetic stimulation
reveals a hemispheric asymmetry correlate of intermanual differences in motor performance.
Neuropsychologia. 1997; 35:1355-1363.
88. Travis Davidson, Francois Tremblay. Hemispheric Differences in Corticospinal Excitability
and in Transcallosal Inhibition in Relation to Degree of Handedness. PLOS ONE. 2013; 8:
e70286.
89. Scotto C. Livingston, Howard P. Goodkin, Christopher D. Ingersoll, et al. The influence of
gender, hand dominance, and upper extremity length on motor evoked potentials. Journal of
Clinical Monitoring and Computing. 2010; 24:427-436.
150
90. C. Civardi, A. Cavalli, P. Naldi, et al. Hemispheric asymmetries of cortico-cortical
connections in human hand motor areas. Clinical Neurophysiology. 2000; 111:624-629.
91. Kazumoto Shibuya, Susanna B Park, James Howells, et al. Laterality of motor cortical
function measured by transcranial magnetic stimulation threshold tracking. Muscle & Nerve.
2017; 3:424-427.
92. Medical Research Concil. Aids to the examination of the peripheral nervous system. London:
Her Majesty’s Stationery Office; 1976. p.1-2
93. Ritsuko Hanajima, Yoshikazu Ugawa, Yasuo Terao, et al. Mechanisms of intracortical I-wave
facilitation elicited with paired-pulse magnetic stimulation in humans. Journal of Physiology.
2002; 538:253-261.
94. Takanori Yokota, Akiko Yoshino, Akira Inaba, et al. Double cortical stimulation in
amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 1996;
61:596-600.
95. Ulf Ziemann, Martin Winter, Carl D. Reimers, et al. Impaired motor cortex inhibition in
patients with amyotrophic lateral sclerosis. Neurology. 1997; 49:1292-1298.
96. Martin Sommer, Frithjof Tergau, Stephan Wischer, et al. Riluzole does not have an acute
effect on motor thresholds and the intracortical excitability in amyotrophic lateral sclerosis.
J Neurol. 1999; 246(suppl 3): Ⅲ/22-Ⅲ/26.
97. Stefan K, Kunesch E, Benecke R, et al. Effects of riluzole on cortical excitability in patients
with amyotrophic lateral sclerosis. Ann Neurol. 2001; 49:536-9.
98. Giampietro Zanette, Stefano Tamburin, Paolo Manganotti, et al. Different mechanisms
contribute to motor cortex hyperexcitability in amyotrophic lateral sclerosis. Clinical
Neurophysiology. 2002; 113:1688-1697.
99. Walter Paulus, Joseph Classen, Leonardo G. Cohen, et al. State of the art: Pharmacologic
effects on cortical excitability measures tested by transcranial magnetic stimulation. Brain
Stimulation. 2008; 1:151-63.
100. Aurore Brunet, Geoffrey Stuart-Lopez, Thibaut Burg, et al. Cortical Circuit Dysfunction as
a Potential diver of Amyotrophic Lateral Sclerosis. Front. Neurosci. 2020; 14:363.
101. Kuninobu Nihei, Ann C. McKee, Neil W. Kowall, et al. Patterns of neuronal degeneration in
the motor cortex of amyotrophic lateral sclerosis patients. Acta Neuropathol. 1993; 86:55-64.
102. Susanne Perti, Klaus Krampfl, Fariba Hashemi, et al. Distribution of GABAA Receptor
mRNA in the motor cortex of ALS patients. Journal of Neuropathology and Experimental
Neurology. 2003; 62:1041-1051.
103. Lauren Taylor Rosenblum, Davide Trotti, et al. EAATs and molecular signature of
amyotrophic lateral sclerosis. Adv Neurobiol. 2017; 16:117-136.
104. Nagai M, Re DB, Nagata T, Chalazonitis A, et al. Astrocytes expressing ALS-linked mutated
151
SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci 2007 5;10(5):615–22.
105. Kazumoto Shibuya, Neil G. Simon, Nimeshan Geevasinga, et al. The evolution of motor
cortical dysfunction in amyotrophic lateral sclerosis. Clinical Neurophysiology. 2017;
128:1075-1082.
106. Mehdi A.J. Van den Bos, Mana Higashihara, Nimeshan Geevasinga, et al. Imbalance of
cortical facilitatory and inhibitory circuits underlies hyperexcitability in ALS. Neurology.
2018; 00: e1-e8.
107. Nicola Modugno, Antonio Curra, Francesca Gilio, et al. Transcranial Magnetic Stimulation
in Movement Disorders. Magnetic Stimulation in Clinical Neurophysiology. 2005; 181-195.
108. T. Dharmadasa, J. Howells, J.M. Matamala, et al. Cortical inexcitability defines an adverse
clinical profile in amyotrophic lateral sclerosis. European Journal of Neurology. 2020; 0:1-8.
109. Hideyuki Matsumoto, Ritsuko Hanajima, Masashi Hamada, et al. Double-Pulse Magnetic
Brain Stem Stimulation: Mimicking Successive Descending volleys. J Neurophysiol. 2008;
100:3437-3444.
110. Yoshikazu Ugawa, Yoshikazu Uesaka, Yasuo Terao, et al. Magnetic Stimulation of
Corticospinal Pathways at the Foramen Magnum Level in Humans. Ann Neurol. 1994;
36:618-624.
111. Blair Calancie, Dongliang Wang, Eufrosina Young, et al. Four-pulse transcranial magnetic
stimulation using multiple conditioning inputs. Normative MEP responses. Experimental
Brain Research. 2018; 236:1205-1218.
112. Ritsuko Hanajima, Yoshikazu Ugawa, Yasuo Terao, et al. Mechanisms of intracortical I-wave
facilitation elicited with paired-pulse magnetic stimulation in humans. Journal of Physiology.
2002; 538:253-261.
113. Callum G. Brownstein, Loic Espeit, Nicolas Royer, Thomas Lapole, Guillaume Y. Millet.
Fatigue-induced in short-interval intracortical inhibition and the silent period with stimulus
intensities evoking maximal versus submaximal responses. J Appl Physiol. 2020; 129:205217.
152
ADM
abductor digiti minimi
小指外転筋
AE-COPD
acute exacerbation of chronic obstructive
慢性閉塞性肺疾患の急性増悪
pulmonary disease
ALS
amyotrophic lateral sclerosis
筋萎縮性側索硬化症
ALSFRS
Amyotrophic Lateral Sclerosis Functional Rating Scale
AMT
active motor threshold
活動時運動閾値
ANOVA
analysis of variance
分散分析
ATR
Achilles tendon reflex
アキレス腱反射
AUC
area under the curve
BB/Bi
Biceps brachii
BI
Barthel Index
BrTR
brachioradial tendon reflex
腕橈骨筋腱反射
BTR
biceps tendon reflex
上腕二頭筋腱反射
CMCT
central motor conduction time
中枢運動伝導時間
CS
conditioning stimulation
条件刺激
CSP
cortical silent period
皮質サイレントピリオド
Del
deltoid
三角筋
EAAT2
excitatory amino acid transporter 2
興奮性アミノ酸トランスポータ
上腕二頭筋
ー2
ECR
extensor carpi radialis
橈側手根伸筋
EHI
Edinburgh Handedness Inventory
EMG
electromyography
針筋電図
EPSP
excitatory postsynaptic potential
興奮性シナプス後電位
FDI
first dorsal interosseous
第一背側骨間筋
FHB
flexor hallucis brevis
短母指屈筋
FTD
frontotemporal degeneration
前頭側頭変性症
GABA
gamma-aminobutyric acid
γアミノ酪酸
GC
gastrocnemius
腓腹筋
ICC
intraclass correlation coefficient
級内相関係数
ICF
intracortical facilitation
皮質内促通
I/O curve
input-output curve
ISI
interstimulus interval
刺激間間隔
LE
lower extremity
下肢
153
LMN
lower motor neuron
下位運動神経
M1
primary motor area
一次運動野
MEP
motor evoked potential
運動誘発電位
MND
motor neuron disease
運動神経疾患
MRC
Medical Research Council
mRS
modified Rankin Scale
MS
multiple sclerosis
多発性硬化症
MSA
multiple system atrophy
多系統萎縮症
MSO
maximum stimulator output
最大刺激出力
MT
motor threshold
運動閾値
MUP
motor unit potential
運動単位電位
NS
not significant
OP
opponens pollicis
PEST
parameter estimation by sequential testing
PLS
primary lateral sclerosis
原発性側索硬化症
PMA
progressive muscle atrophy
進行性筋萎縮症
ppTMS
paired-pulse paradigm TMS
二発刺激
PTR
patellar tendon reflex
膝蓋腱反射
PV
parvalbumin
Quad
quadriceps femoris
rEEC
revised El Escorial criteria
RMT
resting motor threshold
ROC
receiver operating characteristic
SICF
short-interval intracortical facilitation
短潜時皮質内促通
SICI
short-interval intracortical inhibition
短潜時皮質内抑制
spTMS
single pulse TMS
単発刺激
TA
tibialis anterior
前脛骨筋
TH
threshold hunting
閾値探索
TMS
transcranial magnetic stimulation
経頭蓋磁気刺激
TS
test stimulation
試験刺激
TT
threshold tracking
閾値追跡
TTR
triceps tendon reflex
上腕三頭筋腱反射
UE
upper extremity
上肢
母指対立筋
大腿四頭筋
安静時運動閾値
154
...
論文の公開元へ
